Literature DB >> 21861810

Recent advances in the field of 16-membered macrolide antibiotics.

W Cui1, S Ma.   

Abstract

The continuing emergence of bacterial resistance has provided an incentive for recent intensified research on macrolide antibiotics. Belonging to the macrolide family, 16-membered macrolides also experience a renewed interest in further exploration. The medicinal potential of 16-membered macrolides in search for new antibacterials stems from some advantages over 14-membered macrolides, such as gastrointestinal tolerability, structural flexibility, and lack of inducible resistance. Thus, compared with abundant articles on various 14-membered macrolide derivatives in the literature, this review will highlight some representative 16-membered macrolide antibiotics and their recently discovered analogs. Furthermore, the action and resistance mechanisms of 16-membered macrolide antibiotics will be elucidated as well to assist the drug design.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861810     DOI: 10.2174/138955711797247734

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  4 in total

1.  Dinuclear vs. Mononuclear Copper(II) Coordination Species of Tylosin and Tilmicosin in Non-Aqueous Solutions.

Authors:  Ivayla Pantcheva; Radoslava Stamboliyska; Nikolay Petkov; Alia Tadjer; Svetlana Simova; Radostina Stoyanova; Rositza Kukeva; Petar Dorkov
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

2.  Erythromycin loaded by tetrahedral framework nucleic acids are more antimicrobial sensitive against Escherichia coli (E. coli).

Authors:  Yue Sun; Yuhao Liu; Bowen Zhang; Shirong Shi; Tao Zhang; Dan Zhao; Taoran Tian; Qirong Li; Yunfeng Lin
Journal:  Bioact Mater       Date:  2021-01-23

3.  Midecamycin Is Inactivated by Several Different Sugar Moieties at Its Inactivation Site.

Authors:  Ru Lin; Li-Li Hong; Zhong-Ke Jiang; Ke-Meng Li; Wei-Qing He; Jian-Qiang Kong
Journal:  Int J Mol Sci       Date:  2021-11-23       Impact factor: 5.923

4.  In Vitro and In Vivo Activities of Tilmicosin and Acetylisovaleryltylosin Tartrate against Toxoplasma gondii.

Authors:  Yazhen Ma; Xinru Cao; Hui Wang; Xingju Song; Dandan Hu
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.